Krystal Biotech Inc. (KRYS) - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-01-31
5:52 pm
Purchase
2022-12-3113GKRYSTAL BIOTECH INC
KRYS
BlackRock Inc.
BLK
1,698,425
6.600%
92,929increase
(+5.79%)
Filing
History
2022-02-14
5:07 pm
Purchase
2021-12-3113GKRYSTAL BIOTECH INC
KRYS
Redmile Group LLC1,820,898
7.300%
145,862increase
(+8.71%)
Filing
History
2022-02-14
4:49 pm
Purchase
2021-12-3113GKRYSTAL BIOTECH INC
KRYS
Point72 Asset Management, L.P.1,860,670
7.500%
517,428increase
(+38.52%)
Filing
History
2022-02-09
09:22 am
Purchase
2022-02-0813GKRYSTAL BIOTECH INC
KRYS
FMR LLC1,978,289
7.879%
725,903increase
(+57.96%)
Filing
History
2022-02-03
4:41 pm
Purchase
2021-12-3113GKRYSTAL BIOTECH INC
KRYS
BlackRock Inc.
BLK
1,605,496
6.400%
198,148increase
(+14.08%)
Filing
History
2021-12-06
5:22 pm
Purchase
2021-12-0313GKRYSTAL BIOTECH INC
KRYS
Point72 Asset Management, L.P.1,343,242
5.400%
1,343,242increase
(New Position)
Filing
History
Goto Prev, 0, 1